Original articleAtrial Fibrillation Is Associated With Lower Cognitive Performance in the Framingham Offspring Men
Section snippets
Study Sample
The Framingham Offspring Study participants, recruited in 1971, were biological children or related by marriage to a biological child of members of the original Framingham Heart Study cohort. Participants were examined 7 times during a 30-year period to identify risk factors for cardiovascular and cerebrovascular disease. All 1506 male Offspring Study members who participated in the seventh examination were eligible for the current investigation. Women were not excluded from the sample by
Results
To evaluate potential sample bias, men who participated in this study were compared with those men who were excluded because of lack of neuropsychologic test data. The pattern of results was the same for men in the AFIB and non-AFIB groups. In general, men who were included in our study exhibited lower (P < .05) mean systolic blood pressure (126 v 128 mm Hg), lower prevalence of hypertension (33% v 41%), and drank less alcohol (101 v 118 mL/wk) but did not differ from participants with respect
Discussion
Compared with their counterparts in normal sinus rhythm, men with a history of AFIB performed more poorly on a composite of cognitive abilities and on a range of cognitive performance measures. In our study, as in the two previous large community-based studies,15, 16 AFIB was associated with a measure of overall cognitive ability. Ott et al16 used the MMSE and Kilander et al15 used the MMSE and the Trails A and B tests in a composite score. In our study, global ability was indexed by a
Acknowledgment
The authors wish to express their appreciation to Greg Dore for his assistance in technical aspects of manuscript preparation and copy editing, and to Amanda Goodell and Anna Sweeney (University of Maine) for their diligent assistance in copy editing.
References (45)
- et al.
Prevalence of atrial fibrillation in elderly subjects (the cardiovascular health study)
Am J Cardiol
(1994) - et al.
Systemic arterial embolism in rheumatic heart disease
Am Heart J
(1951) - et al.
The development of coronary heart disease in relation to sequential biennial measures of cholesterol in the Framingham study
J Chronic Dis
(1966) Atrial fibrillation: Current understandings and research imperatives
J Am Coll Cardiol
(1993)- et al.
Epidemiological features of atrial fibrillation: The Framingham study
N Engl J Med
(1982) - et al.
Atrial fibrillation: A major contributor to stroke in the elderly
Arch Intern Med
(1987) - et al.
ABC of atrial fibrillation: Etiology, pathophysiology, and clinical features
BMJ
(1995) The management of rheumatic heart disease in relation to systemic arterial embolism
Prog Cardiovasc Dis
(1960)- et al.
Atrial fibrillation and the risk of cerebral white matter lesions
Neurology
(2000) - et al.
Impact of atrial fibrillation on the risk of death: The Framingham study
Circulation
(1998)
Frequency and determinants of pre-stroke dementia in a Chinese cohort
J Neurol
Atrial fibrillation and cognitive function: Case-control study
J Neurol Neurosurg Psychiatry
Neuropsychological deficits in asymptomatic atrial fibrillation
Acta Neurol Scand
Atrial fibrillation and cognitive disorders in older people
J Am Geriatr Soc
Chronic atrial fibrillation and low cognitive function: Letters to the editor
Stroke
Atrial fibrillation is an independent determinant of low cognitive function: A cross-sectional study in elderly men
Stroke
Atrial fibrillation and dementia in a population-based study: The Rotterdam study
Stroke
Framingham stroke risk profile and lowered cognitive performance
Stroke
Dementia after stroke: The Framingham study
Stroke
The preclinical phase of Alzheimer’s disease: A 22-year prospective study of the Framingham cohort
Arch Neurol
Plasma homocysteine as a risk factor for dementia and Alzheimer’s disease
N Engl J Med
Clinical diagnosis of Alzheimer’s disease: NICDS-ADRA work group under the auspices of the Department of Health and Human Services task force on Alzheimer’s disease
Neurology
Cited by (0)
Supported by the National Heart, Lung, and Blood Institute (NHLBI)’s Framingham Heart Study; the National Institutes of Health (NIH)/NHLBI contract NO1-HC-25195; NIH/National Institute on Aging (NIA) grant 5RO1-AGO8122; NIH/NIA grant 5RO1-AG16495; NIH/National Institute of Neurological Disorders and Stroke grant 5RO1-NS17950; NIH/NHLBI grant NO1-HC-25195; NIH/NHLBI grant 1RO1-HL081290; NIH/NHLBI grant 1RO1-HL67358; the Boston University Alzheimer’s Disease Center (grant P30 AG13846); and a midcareer investigator award NIH (2K24HL004334) (Dr. Vasan).